ERYP Erytech Pharma S.A. ADRs

Erytech Pharma is a France based clinical-stage biopharmaceutical company. It is engaged conducting activities in research and development in the fields of treatment for acute leukemia and other orphan diseases. This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:ERYP.

$3.09  -0.20 (-6.08%)
As of 10/26/2021 15:58:54 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  France
Country of incorporation:  France
IPO date:  07/05/2016
Outstanding shares:  27,729,047
Average volume:  121,938
Market cap:   $151,955,178
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    29604W108
ISIN:        US29604W1080
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   2.49
PS ratio:   0.00
Return on equity:   -182.31%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy